[ORL and speech aspects in DiGeorge syndrome]

Area of Science:

• Medical Genetics
• Developmental Biology
• Clinical Medicine

Background:

• DiGeorge syndrome is characterized by congenital heart defects, immune deficiency, hypoparathyroidism, and facial dysmorphism.
• Molecular cytogenetics, specifically fluorescence in situ hybridization (FISH), has identified a 22q11 microdeletion in most DiGeorge syndrome cases.
• Significant overlap exists between DiGeorge syndrome, velocardiofacial syndrome, and other conotruncal cardiac anomalies associated with the 22q11 microdeletion.

Observation:

• This study focuses on a partial DiGeorge syndrome case, emphasizing otological, maxillo-facial, speech, and language aspects.
• Repeated audiometric testing is crucial to rule out hearing impairments as a cause of speech and language difficulties.
• Comprehensive speech and language assessments are necessary to determine the extent of velar insufficiency (rhinolalia) and its psycho-affective component.

Findings:

• The 22q11 microdeletion is a key genetic cause for DiGeorge syndrome and related conditions.
• Speech and language impairments, including velar insufficiency, are significant clinical manifestations.
• Early and thorough audiological and speech-language evaluations are vital for effective management.

Implications:

• Early identification and intervention for speech and language issues are critical for improving patient outcomes.
• Management strategies may include speech therapy and, in some cases, surgical intervention for palatal abnormalities.
• Understanding the spectrum of 22q11 microdeletion disorders aids in comprehensive patient care and genetic counseling.